logo

For the Inventor, By the Inventor

Rho, Italy

Paolo Tavecchia

This inventor holds 6 USPTO granted patents. Top assignees: Gruppo Lepetit, Biosearch Italia S.p.a.. Active years: 1992-1999.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Paolo Tavecchia. Retrieved from https://idiyas.com/inventor/paolo-tavecchia

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 6

% Patents Active = 100.0

Average Co-Inventor Count = 3.2

ph-index = 5

Forward Citations = 53(Granted Patents)


Company Filing History:

goldMedal5 out of 188 
 
Gruppo Lepetit
 patents
silverMedal1 out of 9 
 
Biosearch Italia S.p.a.
 patents

Years Active: 1992-1999

Loading Chart...
6 patents (USPTO):Explore Patents
1. 6008225 - Derivatives of antibiotic GE2270 factors C.sub.2a, D.sub.2 and E (1999-12-28),
2. 5843890 - Antibiotic GE 2270 factors B.sub.1, B.sub.2, C.sub.1, C.sub.2, D.sub.1, (1998-12-01),
3. 5747295 - Antibiotic GE 2270 factors B.sub.1, B.sub.2, C.sub.1, C.sub.2, D.sub.1, (1998-05-05),
4. 5599791 - Amides of antibiotic GE 2270 factors (1997-02-04),
5. 5547666 - Antibiotic GE 2270 factors A.sub.1, A.sub.2, A.sub.3 and H (1996-08-20),
6. 5139778 - Antibiotic GE 2270 factors A.sub.1, A.sub.2, A.sub.3 and H (1992-08-18),

Title: Paolo Tavecchia: Innovator in Antibiotic Development

Introduction

Paolo Tavecchia is a notable inventor based in Rho, Italy. He has made significant contributions to the field of antibiotics, holding a total of 6 patents. His work focuses on developing new antibiotic substances that have the potential to treat infectious diseases.

Latest Patents

Among his latest patents are derivatives of antibiotic GE2270 factors, including C.sub.2a, D.sub.2, and E. He has also patented antibiotic GE 2270 factors B.sub.1, B.sub.2, C.sub.1, C.sub.2, D.sub.1, D.sub.2, E, and T. These inventions are directed towards new antibiotic substances, their addition salts, pharmaceutical compositions, and their use as medicaments, particularly in treating infections caused by susceptible microorganisms. Additionally, these substances are also considered for use as animal growth promoters.

Career Highlights

Throughout his career, Paolo Tavecchia has worked with prominent companies in the pharmaceutical industry, including Gruppo Lepetit S.p.a. and Biosearch Italia S.p.a. His expertise in antibiotic development has positioned him as a key figure in the field.

Collaborations

Paolo has collaborated with notable professionals such as Enrico Selva and Ermenegildo Restelli. These partnerships have contributed to the advancement of his research and innovations in antibiotic substances.

Conclusion

Paolo Tavecchia's contributions to antibiotic development through his patents and collaborations highlight his importance in the field of pharmaceuticals. His work continues to influence the treatment of infectious diseases and animal health.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…